Response to "Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: Results from the final analysis of the randomized phase 2 Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT) trial at 42 months".

Authors :: Villani A
Fabbrocini G
Costa C
Scalvenzi M
Source :: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2021 Jun; Vol. 84 (6), pp. e299-e300. Date of Electronic Publication: 2021 Mar 04.
Publication Year :: 2021
Abstract: Competing Interests: Conflicts of interest None disclosed.

Subjects :: Biphenyl Compounds
Humans
Pyridines
Carcinoma, Basal Cell drug therapy
Skin Neoplasms drug therapy

Full Text Access

Tools